Alexion Pharmaceuticals, Inc. (ALXN) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Financial Fact:
Interest expense: -23.79M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Interest expense: -23.79M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reported Q2 EPS of $1.12, $0.05 better than the analyst estimate of $1.07. Revenue for the quarter came in at $512.5 million versus the consensus estimate of $509.54 million.
For earnings history and earnings-related data on Alexion Pharmaceuticals, Inc. (ALXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
- Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
